COMMENTThe uncertainty surrounding Solvency II is an increasing concern. In this article Graham Olsen, Senior Managing Consultant in IBM’s Global Business Services considers how firms can leverage their investments beyond Solvency II. For some insurers, Solvency II will have been perceived as a huge waste of time and money: a regulatory hurdle and no more. Insurers may have struggled through treating the regulation as a compliance exercise with little to show for it at the end. Other insurers, however, will turn Solvency II into a success story, and leverage it to deliver significant benefits, both in the short and longer term. While uncertainty about the implementation date continues, insurers need to be especially careful about securing the benefits of their Solvency II programmes. Extended delivery schedules would be likely to increase exposure to risk and defer benefit realisation. Organisations often find it difficult to maintain attention and energy on overlong initiatives. Controlled completion and implementation of these programmes is critical for sponsors if they are to avoid failure and make a difference to their organisation. This article examines the steps successful insurance leaders will take.